Clinical Trial: Study of Cannabidiol (CBD) in Healthy Volunteers

U.S., Feb. 29 -- ClinicalTrials.gov registry received information related to the study (NCT06286839) titled 'Study of Cannabidiol (CBD) in Healthy Volunteers' on Oct. 7, 2023.

Brief Summary: This was a prospective, single-centre, open label, randomized, two-arm, parallel design study to evaluate the effect of four-weeks consumption of active study product on primary endpoint in healthy adults

Study Type: Interventional

Condition: * Immune System and Related Disorders

* Immune System Diseases

Intervention: Dietary Supplement: Cannabidiol (CBD)

Cannabidiol (CBD), a non-psychoactive component of Cannabis sativa L.

Recruitment Status: Completed

Published by HT Digital Content Services with permission from Health Daily Digest....